Reduanul H. Kavey

Kushtia, C 7003, Bangladesh

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications

GC-MS Guided Phytochemical Fingerprinting and Multi-Target Therapeutic Evaluation of Ixora chinensis Lam. Leaves: Insights into Its Hypoglycemic and Analgesic Activities.

GC-MS Guided Phytochemical Fingerprinting and Multi-Target Therapeutic Evaluation of Ixora chinensis Lam. Leaves: Insights into Its Hypoglycemic and Analgesic Activities.

Journal: Biology
Published: March 19, 2026

Multi-target therapeutic potential of Neem (Azadirachta indica) phytochemicals in Alzheimer's disease: an integrative network pharmacology and molecular dynamics simulation approach.

Multi-target therapeutic potential of Neem (Azadirachta indica) phytochemicals in Alzheimer's disease: an integrative network pharmacology and molecular dynamics simulation approach.

Journal: In silico pharmacology
Published: March 18, 2025

Binding Interaction and Stability Analysis of Quercetin and its Derivatives as Potential Inhibitors of Triple Negative Breast Cancer (TNBC) against PARP1 Protein: An in-silico Study.

Binding Interaction and Stability Analysis of Quercetin and its Derivatives as Potential Inhibitors of Triple Negative Breast Cancer (TNBC) against PARP1 Protein: An in-silico Study.

Journal: Current pharmaceutical design
Published: November 24, 2024

Discovery of novel PARP1 inhibitors through computational drug design approaches.

Discovery of novel PARP1 inhibitors through computational drug design approaches.

Journal: Computational biology and chemistry
Published: November 16, 2024

Network Pharmacology and In silico Elucidation of Phytochemicals Extracted from Ajwa Dates (Phoenix dactylifera L.) to Inhibit Akt and PI3K Causing Triple Negative Breast Cancer (TNBC).

Network Pharmacology and In silico Elucidation of Phytochemicals Extracted from Ajwa Dates (Phoenix dactylifera L.) to Inhibit Akt and PI3K Causing Triple Negative Breast Cancer (TNBC).

Journal: Current pharmaceutical design
Published: August 09, 2024
Showing 1-5 of 5

Last Updated: 09/26/2026